Company Events - 7 Days Ahead Events

Economic Events - 7 Days Ahead Events

Company Events - Today's Events

Economic Events - Today's Events

Company Events - Month Ahead Events

Economic Events - Month Ahead Events

Company Events - Tomorrow's Events

Economic Events - Tomorrow's Events

Director Deals - (OSB)

Andrew Golding, Chief Executive Officer, sold 27,324 shares in the company on the 20th March 2025 at a price of £4.64. The Director now holds 857,119 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (OSB)

Andrew Golding, Chief Executive Officer, has transferred in 57,931 shares in the company on the 20th March 2025 at a price of £0.00. The Director now holds 884,443 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (OTB)

Shaun Morton, Financial Director, bought 765 shares in the company on the 20th March 2025 at a price of £2.35. The Director now holds 196,191 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (VCT)

Urmi Richardson, Non Executive Director, bought 100 shares in the company on the 21st March 2025 at a price of £9.58. The Director now holds 100 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Jeannie Lee, Non Executive Director, bought 498 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 2,090 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Harry Dietz, Non Executive Director, bought 498 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 7,844 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Anne Beal, Non Executive Director, bought 498 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 8,296 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Elizabeth Anderson, Non Executive Director, bought 496 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 4,856 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Jesse Goodman, Director, bought 498 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 31,926 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Vishal Sikka, Non Executive Director, bought 1,714 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 18,388 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Wendy Becker, Non Executive Director, bought 536 shares in the company on the 20th March 2025 at a price of £15.15. The Director now holds 2,903 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Charles Bancroft, Non Executive Director, bought 3,938 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 68,266 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Jonathan Symonds, Chairman, bought 1,750 shares in the company on the 20th March 2025 at a price of £15.14. The Director now holds 83,507 shares representing 0.00% of the shares in issue. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (GSK)

Hal Barron, Executive Director, bought 498 shares in the company on the 20th March 2025 at a price of $19.64. The Director now holds 738,107 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (ESNT)

Steve Good, Non Executive Director, bought 35,000 shares in the company on the 20th March 2025 at a price of £1.09. The Director now holds 105,000 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (WG.)

Ken Gilmartin, Chief Executive Officer, bought 15,249 shares in the company on the 20th March 2025 at a price of £0.44. The Director now holds 1,259,700 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (WG.)

Ken Gilmartin, Chief Executive Officer, bought 15,249 shares in the company on the 20th March 2025 at a price of £0.44. The Director now holds 1,259,700 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (WG.)

Ken Gilmartin, Chief Executive Officer, has transferred in 7,625 shares in the company on the 20th March 2025 at a price of £0.00. The Director now holds 1,267,325 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (SHI)

Ian Ashton, Financial Director, exercised 997,060 shares in the company on the 18th March 2025 at a price of £0.00. The Director now holds 2,372,935 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (SHI)

Ian Ashton, Financial Director, sold post-exercise 470,273 shares in the company on the 18th March 2025 at a price of £0.13. The Director now holds 2,305,769 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (SHI)

Ian Ashton, Financial Director, sold post-exercise 190,130 shares in the company on the 18th March 2025 at a price of £0.13. The Director now holds 2,115,639 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (SHI)

Ian Ashton, Financial Director, exercised 403,107 shares in the company on the 18th March 2025 at a price of £0.00. The Director now holds 2,776,042 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (LGEN)

Antonio Simoes, Chief Executive Officer, has transferred in 419,739 shares in the company on the 20th March 2025 at a price of £0.00. The Director now holds 1,351,916 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (LGEN)

Antonio Simoes, Chief Executive Officer, sold 197,279 shares in the company on the 20th March 2025 at a price of £2.44. The Director now holds 1,154,637 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (COA)

Jackie Callaway, Executive Director, exercised 1,000,328 shares in the company on the 20th March 2025 at a price of £0.00. The Director now holds 1,333,817 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more

Director Deals - (COA)

Jackie Callaway, Executive Director, sold post-exercise 472,040 shares in the company on the 20th March 2025 at a price of £0.83. The Director now holds 861,777 shares. Story provided by StockMarketWire.com Director deals data provided by ... Read more